ARCHIVES

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

This article is from The Cancer Letter archive.

Vol. 13 No. 36 | September 18, 1987

Download PDF Visit The Full Archive

Related Articles

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999